Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Pregabalin CR vs IR in Healthy Males
NCT02103647Phase 1Completed
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- May 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pregabalin in neuropathic pain, epilepsy, generalized anxiety disorder (GAD) and 1 more (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoint: Blood concentration of pregabalin. Started May 2013; status: completed.
02
Drugs
pregabalin
03
Conditions
neuropathic painepilepsygeneralized anxiety disorder (GAD)fibromyalgia (FM)
Beyond the preview
Go deeper on NCT02103647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02103647.